FS4-20207-57232
4 vaccinations
6 coded responses
38 check-ins
6 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 66+
- ZIP prefix
- 232 / VA
- Registered
- 2021-02-06
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-06
Registered in v-safe
-
2021-02-06
Dose 1 — Moderna
- 2021-02-06
- 2021-02-07
- 2021-02-08
- 2021-02-09
- 2021-02-10
-
2021-02-11
Health check-in — days 1–6 daily, dose 1Feeling: Good · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-02-14
- 2021-02-24
- 2021-02-28
- 2021-03-06
-
2021-03-10
Dose 2 — Moderna
-
2021-03-22
Survey response — day 7, dose 2MedDRA: Medical observation, Renal disorder — Feeling: Good · Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: I now am being monitored for kidney function.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-24
Survey response — day 14, dose 2MedDRA: Low density lipoprotein increased, Office visit, Renal impairment — Feeling: Good · Get care from a doctor or other healthcare professionalFree text: Symptoms: Ldl high and reduced kidney function. Primary care physician changed medication from HTCZ water pill to Losartan. · Healthcare visit (other): 90 day follow-up office visit.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-24
Report sent to call center — day 14, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-03-31
- 2021-04-08
-
2021-04-14
Survey response — day 35, dose 2MedDRA: Laboratory test abnormal, Renal impairment, Unevaluable event — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Symptoms: Seeing my Primary care physician on Friday to check my kidney function. · Healthcare visit (other): Routine bloodwork showed decrease in kidney function.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-14
Report sent to call center — day 35, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-04-21
- 2021-06-11
- 2021-09-10
-
2021-10-26
Dose 3 — Moderna
- 2021-11-01
- 2021-11-02
- 2021-11-09
-
2021-11-18
Survey response — day 21, dose 3MedDRA: Injection site pruritus, Self-medication — Feeling: GoodFree text: The injection site started itching. It lasted two days . I put an anti-itch ointment (blue star) on it abd it stopped.MedDRA releases: 2024-11 · check-in free text available
- 2021-11-24
- 2021-11-30
-
2021-12-08
Survey response — day 42, dose 3MedDRA: Glycosylated haemoglobin increased, Hepatic function abnormal, Office visit — Feeling: Fair · Be unable to do your normal daily activitiesFree text: My A1C levels have increased and my liver function is boarderline. My doctor is monitoring the effect of a change in medication and diet as well as an increase in exercise over the next 3 months.MedDRA releases: 2024-11 · check-in free text available
-
2022-01-07
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
-
2022-01-07
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
-
2022-01-25
Survey response — 3 months, dose 3MedDRA: Influenza, Laboratory test abnormal, Oropharyngeal pain, Quarantine, Somnolence, Unevaluable event — Feeling: Fair · Be unable to do your normal daily activitiesFree text: I tested positive and had some symptoms, sore throat, temp., flu symptoms, sleepy. Still positive after a week. Finally tested negative after two weeks. Quarantined the entire time. Still not 100%, but betterMedDRA releases: 2024-11 · check-in free text available
-
2022-04-15
Dose 4 — Moderna
-
2022-04-18
Health check-in — days 1–6 daily, dose 4Feeling: Good · Chills, Muscle or body achesAdult check-in
-
2022-04-19
Health check-in — days 1–6 daily, dose 4Feeling: Good · Chills, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2022-04-20
- 2022-04-22
- 2022-05-01
- 2022-05-07
- 2022-05-13
- 2022-05-20
- 2022-05-27
- 2022-07-16
- 2022-10-14
- 2023-04-17
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-06 | Moderna | |
| 2 | 2021-03-10 | Moderna | |
| 3 | 2021-10-26 | Moderna | No |
| 4 | 2022-04-15 | Moderna | No |
Call center
2 call center cases
2 successful
Free text
Release 6 — day 7, dose 2
Systemic reaction (other): I now am being monitored for kidney function.
Release 6 — day 14, dose 2
Symptoms: Ldl high and reduced kidney function. Primary care physician changed medication from HTCZ water pill to Losartan.
Healthcare visit (other): 90 day follow-up office visit.
Release 7 — day 35, dose 2
Symptoms: Seeing my Primary care physician on Friday to check my kidney function.
Healthcare visit (other): Routine bloodwork showed decrease in kidney function.
Release 10 — day 21, dose 3
Symptoms: The injection site started itching. It lasted two days . I put an anti-itch ointment (blue star) on it abd it stopped.
Release 10 — day 42, dose 3
Symptoms: My A1C levels have increased and my liver function is boarderline. My doctor is monitoring the effect of a change in medication and diet as well as an increase in exercise over the next 3 months.
Release 11 — 3 months, dose 3
Symptoms: I tested positive and had some symptoms, sore throat, temp., flu symptoms, sleepy. Still positive after a week. Finally tested negative after two weeks. Quarantined the entire time. Still not 100%, but better
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Laboratory test abnormal | ✓ | ✓ | ✓ |
| HCVO | Office visit | ✓ | ✓ | ✓ |
| HCVO | Renal impairment | ✓ | ✓ | ✓ |
| SD | Glycosylated haemoglobin increased | · | · | ✓ |
| SD | Hepatic function abnormal | · | · | ✓ |
| SD | Influenza | · | · | ✓ |
| SD | Injection site pruritus | · | · | ✓ |
| SD | Laboratory test abnormal | · | · | ✓ |
| SD | Low density lipoprotein increased | ✓ | ✓ | ✓ |
| SD | Office visit | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Quarantine | · | · | ✓ |
| SD | Renal impairment | ✓ | ✓ | ✓ |
| SD | Self-medication | · | · | ✓ |
| SD | Somnolence | · | · | ✓ |
| SD | Unevaluable event | ✓ | ✓ | ✓ |
| SRO | Medical observation | ✓ | ✓ | ✓ |
| SRO | Renal disorder | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release